Who
Brian B. Hansen
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, Senseonics Holdings; EVP & Chief Commercial Officer, Tandem Diabetes Care; SVP, Global Sales & Service, Gen Probe.
In numbers
- Trades disclosed
- 196
- Buys
- 0
- Sells
- 17
- Bought
- $0
- Sold
- $25.0M
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 10 Feb 2012
- Last trade
- 15 Jun 2026
- Last filed
- 17 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 17 Jun 2026 | SENS Senseonics HoldingsLife-science tools | SEC FORM 4 Code F | $39K5,420 at $7.18 | filing |
| 15 Jun 2026filed 17 Jun 2026 | SENS Senseonics HoldingsLife-science tools | SEC FORM 4 Code F | $39K5,420 at $7.18 | filing |
| 19 May 2026filed 21 May 2026 | SENS Senseonics HoldingsLife-science tools | SEC FORM 4 Code A | —90,253 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | SENS Senseonics Holdingsoption or derivative · Life-science tools | SEC FORM 4 Code A | —124,193 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | SENS Senseonics Holdingsoption or derivative · Life-science tools | SEC FORM 4 Code A | —124,193 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | SENS Senseonics HoldingsLife-science tools | SEC FORM 4 Code A | —90,253 at $0.00 | filing |
| 23 May 2025filed 29 May 2025 | SENS Senseonics Holdingsoption or derivative · Life-science tools | SEC FORM 4 Code A | —1,187,987 at $0.00 | filing |
| 23 May 2025filed 29 May 2025 | SENS Senseonics HoldingsLife-science tools | SEC FORM 4 Code A | —842,084 at $0.00 | filing |
| 27 Nov 2023filed 29 Nov 2023 | TNDM Tandem Diabetes Careoption or derivative · Medical Devices | SEC FORM 4 Code M | —406 at $0.00 | filing |
| 27 Nov 2023filed 29 Nov 2023 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code M | —406 at $0.00 | filing |
| 27 Nov 2023filed 29 Nov 2023 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code F | $2,628135 at $19.47 | filing |
| 15 Nov 2023filed 17 Nov 2023 | TNDM Tandem Diabetes Careoption or derivative · Medical Devices | SEC FORM 4 Code M | —162 at $0.00 | filing |
| 15 Nov 2023filed 17 Nov 2023 | TNDM Tandem Diabetes Careoption or derivative · Medical Devices | SEC FORM 4 Code M | —474 at $0.00 | filing |
| 15 Nov 2023filed 17 Nov 2023 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code A | $151 at $15.47 | filing |
| 15 Nov 2023filed 17 Nov 2023 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code M | —162 at $0.00 | filing |
| 15 Nov 2023filed 17 Nov 2023 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code F | $98354 at $18.20 | filing |
| 15 Nov 2023filed 17 Nov 2023 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code M | —474 at $0.00 | filing |
| 15 Nov 2023filed 17 Nov 2023 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code F | $2,857157 at $18.20 | filing |
| 28 Aug 2023filed 30 Aug 2023 | TNDM Tandem Diabetes Careoption or derivative · Medical Devices | SEC FORM 4 Code M | —407 at $0.00 | filing |
| 28 Aug 2023filed 30 Aug 2023 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code M | —407 at $0.00 | filing |
News
Tandem Diabetes Care (TNDM) Following App Recall Is The Undervalued Case Still IntactTNDM · cedarnews.net · 18 Oct 2026
0 headlines in the last 90 days name Brian B. Hansen; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.